Evaluation of Biomarker Kinetics After Mild Brain Injury Trauma

Completed

Conditions studied: Traumatic Brain Injury

In brief

The primary objective of the clinical trial is to evaluate the effect of time on levels of Ubiquitin C-terminal Hydrolase-L1 (UCH-L1) and Glial Fibrillary Acidic Protein (GFAP) biomarker levels in a population of head injured subjects over the age of 18 presenting acutely with a Glasgow Coma Scale score 13-15 as well as in a group of uninjured control subjects.

Key facts

Study ID

NCT02541123

Run by

Banyan Biomarkers, Inc

People needed

194

Starts

2016-01-01

Expected to finish

2017-02-28

Last updated by the study team

2020-12-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Florida — Gainesville, Florida, United States
• Orlando Regional Medical Center — Orlando, Florida, United States
• Wayne State University — Detroit, Michigan, United States
• Washington University — St Louis, Missouri, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Allegheny Singer Research Institute — Pittsburgh, Pennsylvania, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• Klinikum rechts der Isar of the Technical University of Munich — Munich, Germany
• University of Pecs — Pécs, Hungary
• University of Szeged — Szeged, Hungary

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.